The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 14, 2015

Filed:

Oct. 14, 2009
Applicants:

Christophe Blanchetot, Destelbergen, BE;

Martine Smit, Amsterdam, NL;

Regorius Leurs, Amsterdam, NL;

Sven Jähnichen, Amsterdam, NL;

Dominique Schols, Herentals, BE;

Michael John Scott Saunders, Brussels, BE;

Johannes Joseph Wilhelmus DE Haard, Oudelande, NL;

Peter Vanlandschoot, Bellem, BE;

Peter Verheesen, Ghent, BE;

Inventors:

Christophe Blanchetot, Destelbergen, BE;

Martine Smit, Amsterdam, NL;

Regorius Leurs, Amsterdam, NL;

Sven Jähnichen, Amsterdam, NL;

Dominique Schols, Herentals, BE;

Michael John Scott Saunders, Brussels, BE;

Johannes Joseph Wilhelmus De Haard, Oudelande, NL;

Peter Vanlandschoot, Bellem, BE;

Peter Verheesen, Ghent, BE;

Assignee:

Ablynx N.V., Zwijnaarde, BE;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/00 (2006.01); C07K 16/18 (2006.01); C07K 16/28 (2006.01); C07H 21/04 (2006.01); C12N 5/07 (2010.01); C12N 5/10 (2006.01); C12N 5/16 (2006.01); C12N 5/22 (2006.01); A61K 39/00 (2006.01); A61K 39/395 (2006.01);
U.S. Cl.
CPC ...
C07K 16/2812 (2013.01); C07K 16/2866 (2013.01); A61K 2039/505 (2013.01); C07K 2316/96 (2013.01); C07K 2317/21 (2013.01); C07K 2317/22 (2013.01); C07K 2317/31 (2013.01); C07K 2317/565 (2013.01); C07K 2317/569 (2013.01); C07K 2317/92 (2013.01); C07K 2319/31 (2013.01); Y10S 530/866 (2013.01);
Abstract

The present invention relates to amino acid sequences that are directed against (as defined herein) human cellular receptors for viruses and/or bacteria such as e.g. NANOBODIES specifically recognizing hCD4, hCXCR4, hCCR5, hTLR4, human alphaV integrin, human beta3 integrin, human beta1 integrin, human alpha2 integrin, hCD81, hSR-BI, hClaudin-1, hClaudin-6 and hClaudin-9, as well as to compounds or constructs, and in particular proteins and polypeptides, that comprise or essentially consist of one or more such amino acid sequences. The amino acid sequences may be used to prevent human cell entry of HIV, HCV, adenoviruses, hantavirus, herpesvirus, echo-virus 1 and others.


Find Patent Forward Citations

Loading…